Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities:
Net loss	$ (101,549)	$ (82,771)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	7,964	8,543
Stock-based compensation	97,664	94,113
Amortization of deferred commissions	38,958	39,342
Non-cash operating lease costs	7,442	7,050
Amortization of debt issuance costs	2,471	1,264
Amortization of premium and accretion of discount on marketable securities, net	1,211	(11,288)
Acquired in-process research and development	0	6,653
Changes in assets and liabilities:
Trade receivables	46,534	49,913
Prepaid expenses and other short-term assets	4,208	(10,889)
Deferred commissions	(57,731)	(43,282)
Other long-term assets	(279)	(129)
Trade payables	755	817
Accrued expenses and other short-term liabilities	23,420	(5,882)
Deferred revenues	50,104	37,200
Other long-term liabilities	1,575	272
Net cash provided by operating activities	122,747	90,926
Cash flows from investing activities:
Proceeds from maturities of marketable securities	324,080	157,100
Investment in marketable securities	(229,446)	(576,753)
Proceeds from short-term and long-term deposits	159,405	25,038
Investment in short-term and long-term deposits	(156,089)	(9,233)
Acquisitions, net of cash acquired	(123,514)	0
Purchases of property and equipment	(8,687)	(2,342)
Capitalized internal-use software	(2,509)	0
Purchase of in-process research and development	0	(6,653)
Net cash used in investing activities	(36,760)	(412,843)
Cash flows from financing activities:
Repurchase of common stock	(100,000)	0
Repayment of convertible senior notes	(137)	0
Proceeds from employee stock plans	14,349	16,082
Taxes paid related to net share settlement of equity awards	(28,430)	(37,264)
Proceeds from issuance of convertible senior notes, net of issuance costs	0	450,099
Purchases of capped calls	0	55,522
Net cash provided by (used in) financing activities	(114,218)	373,395
Increase (decrease) in cash and cash equivalents	(28,231)	51,478
Cash and cash equivalents at beginning of period	185,585	230,740
Cash and cash equivalents at end of period	157,354	282,218
Supplemental disclosure of cash flow information:
Cash paid for income taxes	6,825	10,115
Cash paid for interest	7,719	3,184
Supplemental disclosure of non-cash activities:
Liability related to acquisition holdback	3,502	0
Lease liabilities arising from obtaining right-of-use assets	19,064	573
Common stock issued for debt conversion	251,439	6
Issuance costs included in accrued expenses and other short-term liabilities	$ 0	$ 450